Suchergebnisse - "Harter, Philipp"

PubPharm (474)

1

Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer : A study of the European GANNET53 consortium

enthalten in: International journal of cancer | 2024

von Obermayr, E. | Mohr, T. | Schuster, E. | +13

2

Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer-Development of Recommendations for Optimal Assay Performance

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2024

von Romey, M. | Rodepeter, F. | Hattesohl, A. | +13

3

Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Boidot, R. | Blum, M. | Wissler, M. | +21

4

Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma : An Exploratory Analysis of AGO-OVAR11/ICON-7

enthalten in: Laboratory investigation; a journal of technical methods and pathology | 2024

von Heublein, S. | Pfisterer, J. | du Bois, A. | +18

5

Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Westermann, T. | Karabeg, E. | Heitz, F. | +8

6

Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Lorusso, D. | Mouret-Reynier, M. | Harter, P. | +27

7

Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations

enthalten in: JAMA network open | 2024

von Schouten, P. | Schmidt, S. | Becker, K. | +20

8

Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer

enthalten in: Bulletin du cancer | 2024

von Harter, P. | Bogner, G. | Chiva, L. | +21

9

Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease

enthalten in: NPJ genomic medicine | 2024

von Ramachandran, D. | Tyrer, J. | Kommoss, S. | +77

10

Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer

enthalten in: The New England journal of medicine | 2024

von Plante, M. | Kwon, J. | Ferguson, S. | +119

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[48]